Study of an Anti-HER3 Antibody, HMBD-001, With Docetaxel +/- Cetuximab in Advanced Squamous Non-small Cell Lung Cancers

Condition:   Advanced or Metastatic Squamous Non-Small Cell Lung Cancer Interventions:   Drug: HMBD-001;   Drug: Docetaxel;   Drug: Cetuximab Sponsors:   Hummingbird Bioscience;   Merck KGaA, Darmstadt, Germany Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials